A New Level of Performance: How CarnoSyn® 4X Opens Doors in Sports Nutrition (Oct 2026)

Horphag Research's Sébastien Bornet breaks down the clinical science behind Robuvit, exploring how the caffeine-free French oak extract supports mitochondrial energy, mood stability, and stress resilience.

Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.

FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.

The company plans to present Organicaps capsules in size 0, 25 years of UC-II, and liquid-filled capsule technology.

DolCas Biotech is featuring the turmeric-derived ingredient Curcugen in Mānukora’s Mānuka honey and Numin’s cognitive-support drink.

The company says it will feature studies on vitamin K2, choline, folate, and MSM, along with beverage concepts and a first-time pet corner.

The agency’s editorial identifies needs across six areas, including new methods for novel products, gut microbiome data, and AI-supported risk assessment.

The company says it will center on positive aging, with a focus on lutein research beyond vision, the Gutopia platform, and Slendesta for the GLP-1 market.